CARB-X to support lower respiratory tract infection diagnostic by Zeteo

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments, including intubated patients with mechanical ventilation.

EnCharge AI Receives Frost & Sullivan’s 2025 Global Technology Trailblazer Recognition for Advancing Analog AI Compute Innovation

Frost & Sullivan is pleased to announce that EnCharge AI has been awarded the 2025 Global Technology Trailblazer Recognition in the advanced analog AI chips sector for its outstanding achievements in innovation, strategy execution, and market disruption. This recognition acknowledges EnCharge AI’s leadership in delivering next-generation compute solutions and redefining AI deployment with transformative performance at the edge.